Piper Jaffray Goes Overweight Sarepta, Expects FDA To Accept Next Key Drug Filing
August 24, 2015 at 11:29 AM EDT
Shares of Sarepta Therapeutics, Inc. (NASDAQ: SRPT) have risen over 132 percent, year to date, reaching a peak on August 17, of ...